Junli Peptide
Retatrutide
Finnrick tested 7 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Junli Peptide between 7 Jan 2026 and 12 Jun 2026. Test scores average below 4 or some scores below 3, and at least 6 tests, warrant a confident Finnrick Rating of E (Bad).
Finnrick Rating™
Junli Peptide
Retatrutide
Tested 7 Samples
Last test 12 Jun 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Junli Peptide
Samples are tested in commercial labs
Tests Count
7
Scores
AVGMINMAX
Last
12 Jun 2026
First
7 Jan 2026
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Endotoxins | Batch ID | Container | Tested At | Sent By |
| 12 Jun 2026 | View | 10mg | ⚠️ Sample does not contain Retatrutide | n/a | (no batch ID) | No label / Silver crimp / Blue cap | Lab G | Public | |||
| 25 Mar 2026 | View | 10mg | 12mg | +20.0% | 99.60% | n/a | Jan 5, 2026 | Silver Label / Silver Crimp / Clear Blue Cap | Lab G | Public | |
| 25 Mar 2026 | View | 15mg | 15.8mg | +5.3% | 99.70% | n/a | Jan 5, 2026 | Silver Label / Copper Crimp / Clear Cap | Lab G | Public | |
| 16 Mar 2026 | View | 20mg | 19mg | -5.0% | 99.90% | below LOQ | Feb 3, 2026 | White Label / Silver Crimp / Violet Cap | Lab E | Public | |
| 22 Jan 2026 | View | 5mg | 4.1mg | -18.0% | 99.50% | n/a | (no batch ID) | No Label / Silver Crimp / Blue Cap | Lab G | Public | |
| 7 Jan 2026 | View | 20mg | 21.2mg | +6.0% | 99.93% | n/a | (no batch ID) | No Label / Silver Crimp / Violet Cap | Lab E | Public | |
| 7 Jan 2026 | View | 15mg | 16.6mg | +10.7% | 99.70% | n/a | (no batch ID) | No Label / Silver Crimp / Red Cap | Lab G | Public | |